After a bruising week for progressive Democrats that ruled out including a minimum wage hike in the $1.9 trillion COVID-19 relief bill, Congressional business on the legislation will continue next week. This is your Washington Week Ahead for the week of March 1.

Trump Speaks

Former President Donald Trump will speak at the Conservative Political Action Conference, commonly referred to as CPAC, in Orlando on Sunday. It will be his first major public appearance since leaving office and comes after a series of high-profile rebukes from Democrats, including an impeachment trial, while the Republican Party seems divided on how it moves forward. Plus, Sen. Mitch McConnell (R-Ky.) keeps flip-flopping in his support, pledging to support Trump if he runs for the White House again in 2024, just days after holding him responsible for the January 6 insurrection on the Capitol building. Trump has pledged a return of his Make America Great Again movement and CPAC will provide a friendly platform for that exact messaging, further highlighting the hold he still has on his party. 

Stimulus Stalemate

The Senate will begin debate on the American Rescue Plan on March 1, marking the first time the chamber is officially taking up the latest round of coronavirus relief spending. The nearly $2 trillion rescue package includes $1,400 stimulus checks for Americans, billions in federal relief for state, local, and tribal governments, and a huge bucket of money for vaccine rollout. Because the Senate has a legislative filibuster, the bill must adhere to the Byrd Rule, a parliamentary procedure that allows budget reconciliation legislation to pass without being subject to the filibuster. One thing we know for sure is that the final Senate version of the bill, expected to pass next week, will not include a federal minimum wage increase after the parliamentarian determined it would be against the rules. The current federal minimum wage is $7.25 and has remained unchanged since 2009. 

Voting Rights in the Spotlight

Now that the House of Representatives has finished with COVID relief, it’s on to other priorities. In the last Congress, House Democrats passed H.R. 1, the For the People Act, a sweeping election reform bill. It languished in a Republican-controlled Senate. This is a chance for the chamber to try again — but expect a lot of amendments from Republicans, looking to strike down provisions like universal vote-by-mail and extended early voting periods, as well as a national holiday for Election Day. At the same time, the United State Supreme Court will hear arguments on a pair of Voting Rights Act cases that could further erode protections for disadvantaged voters. So in the first week in March, 20 months before the 2022 midterm elections, all eyes in Washington will be on voting rights.

Share:
More In Politics
The Affordable Care Act's 'Family Glitch,' Explained
Krutika Amin, associate director at the Kaiser Family Foundation for the Program on the Affordable Care Act, joins Cheddar Politics to discuss the Biden administration's plan to fix the so-called 'family glitch' in the Affordable Care Act preventing millions of Americans from accessing government-subsidized health plan.
House Votes to Hold Scavino, Navarro in Contempt
Abdallah Fayyad, opinion writer at the Boston Globe, joins Cheddar Politics to discuss the House's vote to hold former Trump aides Dan Scavino and Peter Navarro in contempt of Congress and send the recommendation to the Department of Justice. Fayyad also weighs in on the pressure facing Attorney General Merrick Garland to be more aggressive in prosecuting the January 6 case.
Biden Administration Extends Student Loan Pause to August
Those paying back federal student loans are getting a few extra months of relief. President Biden just announced another extension of the pandemic relief program allowing millions of borrowers to freeze their student loan payments. The pause began in March 2020 and it has been extended six times. Tomas Campos, co-founder and CEO of Spinwheel, joins Cheddar News to discuss.
Doctors, Medical Experts Divided on Second COVID-19 Booster
There has been notable disagreement in the medical community about a fourth COVID-19 vaccine dose. The FDA last week authorized a second booster dose for older and immunocompromised individuals, as some agency officials did not support the idea. The FDA made the decision without meeting with its advisory committee, as it had ahead of its recommendations on the previous COVID-19 vaccine doses. The CDC followed in the footsteps of the FDA and authorized a fourth dose as well. Reports say the agency also did not discuss the move with its own advisory team of vaccine experts. Now, a growing number of doctors are speaking out against the decisions - leaving people confused about whether they should get another vaccine dose. Dr. Julie Morita, a member of the CDC's advisory committee to the director, and the executive vice president of the Robert Wood Johnson Foundation, joins Cheddar News' Closing Bell to discuss.
Load More